BI

Dec 01 2025HEALTH

A New Hope for Eczema Sufferers: How Dupilumab is Changing the Game

Dupilumab is a game-changer for people with severe eczema. It's the first biologic drug approved for this condition. This means it's made from living organisms, not chemicals. It works by targeting specific parts of the immune system that cause inflammation. Eczema is a long-term skin condition. It

reading time less than a minute
Dec 01 2025CRYPTO

Crypto Market Takes Another Hit: Bitcoin and Ethereum Plunge

The crypto market faced another rough day as Bitcoin and Ethereum saw significant drops. Bitcoin fell below $86, 000 before slightly recovering, while Ethereum dropped over 7%. Other cryptocurrencies like Solana and Dogecoin also took a hit, continuing the downward trend from November. This latest

reading time less than a minute
Dec 01 2025CRYPTO

Bitcoin's Rollercoaster: Lessons from 2019

Bitcoin's recent drop below $90, 000 has sparked conversations about what might happen next. Some experts are looking back at 2019 for clues. Back then, Bitcoin's value kept falling even after the Federal Reserve stopped tightening its monetary policy. This time around, the pattern seems eerily simi

reading time less than a minute
Dec 01 2025SCIENCE

The Hidden World Inside Your Eyes

Our eyes are amazing. They let us see the world around us. But did you know there's a tiny world inside your eyes? It's full of tiny messengers. These messengers are like little workers. They help your eyes send important messages. In the retina, there are special cells. These cells have ribbon-like

reading time less than a minute
Dec 01 2025SCIENCE

Small but Mighty: Peptide Mimics Taking on Big Enzyme Jobs

Enzymes called oxidoreductases are like tiny workers in cells. They help with important jobs like making energy and breaking down food. But they have some problems. They can be expensive, not very stable, and don't work well in tough conditions. So, scientists are looking for alternatives. They are

reading time less than a minute
Dec 01 2025OPINION

Rethinking E-Bike Rules: Safety First in Massachusetts

E-bikes are becoming a big part of daily life in Massachusetts. They help people get around, especially in busy cities. But with this rise in popularity, there are growing safety concerns. Recently, a tragic accident in Stoneham has sparked a call for better rules. This is not the first time safety

reading time less than a minute
Dec 01 2025BUSINESS

BillionToOne: A Closer Look at the Biotech Stock Surge

BillionToOne, a biotech company based in Menlo Park, has seen its stock price soar. As of Friday, shares were trading at $130. 18, a significant jump from the initial public offering price of $60. This surge values the company at $5. 91 billion. The company recently raised $273 million by selling 4

reading time less than a minute
Dec 01 2025CRIME

A Legal Battle: Gun and Notes at the Center of a Murder Case

In a New York courtroom, a man named Luigi Mangione is fighting to keep certain evidence out of his upcoming murder trial. The evidence in question includes a handgun and a notebook. Prosecutors believe these items connect Mangione to the killing of a top executive from UnitedHealthcare. Mangione's

reading time less than a minute
Dec 01 2025POLITICS

U. S. Strikes in Caribbean Raise Legal and Ethical Questions

Recent reports have sparked concerns about the legality and ethics of U. S. military strikes in the Caribbean. A high-ranking official reportedly ordered the killing of all individuals aboard a suspected drug boat, even after two survivors were found. This action, if true, could be seen as a serious

reading time less than a minute
Dec 01 2025SCIENCE

High Schoolers Tackle Lyme Disease with CRISPR

In a high school lab, a group of students are using CRISPR to tackle Lyme disease. These students are part of a team competing in an international science competition called iGEM. The team is using CRISPR to detect and treat Lyme disease, which is caused by bacteria transmitted by ticks. The team's

reading time less than a minute